Resultats de la cerca - Pál Miheller

  • Mostrar 1 - 13 resultats de 13
Refinar resultats
  1. 1
    Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohnʼs disease patients

    Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohnʼs disease patients per Pál Miheller, Györgyi Műzes, István Hritz, Gábor Lakatos, István Pregun, Péter L. Lakatos, László Herszényi, Zsolt Tulassay

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature

    Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature per Orsolya Galamb, Balázs Győrffy, Ferenc Sípos, Sándor Spisák, A Németh, Pál Miheller, Zsolt Tulassay, Elek Dinya, Béla Molnár

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre

    Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre per Dorottya Kocsis, Zsuzsanna Tóth, Á Csontos, Pál Miheller, Peter H. Pak, László Herszényi, Miklós Tóth, Zsolt Tulassay, Márk Juhász

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    To cut or not to cut? Extended mesenteric excision during intestinal resection does not impact the postoperative recurrence nor the postoperative complications in Crohn’s disease: a systematic review and meta-analysis

    To cut or not to cut? Extended mesenteric excision during intestinal resection does not impact the postoperative recurrence nor the postoperative complications in Crohn’s disease:... per M. Topala, Petrana Martineková, Anett Rancz, Dániel Sándor Veres, Katalin Lenti, Pál Miheller, B. Erőss, Péter Hegyi, Szabolcs Ábrahám

    Publicat 2025
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA

    Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA per Kinga Tóth, Reinhold Wasserkort, Ferenc Sípos, Alexandra Kalmár, Barnabás Wichmann, Katalin Leiszter, Gábor Valcz, Márk Juhász, Pál Miheller, Árpád V. Patai, Zsolt Tulassay, Béla Molnár

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

    Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy per Tamás Molnár, Péter L. Lakatos, Klaudia Farkas, Ferenc Nagy, Zoltán Szepes, Pál Miheller, Gábor Horváth, Mária Papp, Károly Palatka, Tibor Nyári, Anita Bálint, Katalin Lőrinczy, Tibor Wittmann

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas

    Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas per Árpád V. Patai, Gábor Valcz, Péter Hollósi, Alexandra Kalmár, Bálint Péterfia, Árpád Patai, Barnabás Wichmann, Sándor Spisák, Barbara Kinga Barták, Katalin Leiszter, Kinga Tóth, Ferenc Sípos, Ilona Kovalszky, Zoltán Péter, Pál Miheller, Zsolt Tulassay, Béla Molnár

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD Cohort

    Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with N... per Péter L. Lakatos, I Altorjay, Tamás Szamosi, Károly Palatka, Zsuzsanna Vitális, Judit Tumpek, Sándor Sipka, M. Udvardy, Tamás Dinya, Péter L. Lakatos, Ágota Kovács, Tamás Molnár, Zsolt Tulassay, Pál Miheller, Zsolt Barta, W. Stöcker, J. Papp, Gábor Veres, Mária Papp

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Optimising monitoring in the management of Crohn's disease: A physician's perspective

    Optimising monitoring in the management of Crohn's disease: A physician's perspective per Pavol Papay, Ana Ignjatovic, Konstantinos Κarmiris, Heda Maria Barska dos Santos Amarante, Pál Miheller, Brian G. Feagan, Geert D’Haens, Philippe Marteau, Walter Reinisch, Andreas Sturm, Flávio Steinwurz, Laurence J. Egan, Julián Panés, Édouard Louis, Jean‐Frédéric Colombel, Remo Panaccione

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients

    Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for sur... per Mária Papp, I Altorjay, Gary L. Norman, Zakera Shums, Károly Palatka, Zsuzsanna Vitális, Ildikó Földi, Gabriella Lakos, Judit Tumpek, M. Udvardy, Jolán Hársfalvi, Simon Fischer, Péter L. Lakatos, Ágota Kovács, László Bene, Tamás Molnár, Zsolt Tulassay, Pál Miheller, Gábor Veres, J. Papp, Péter L. Lakatos

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

    Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn... per László Kiss, Tamás Szamosi, Tamás Molnár, Pál Miheller, Péter L. Lakatos, Áron Vincze, Károly Palatka, Zsolt Barta, Beáta Gasztonyi, Á Salamon, Gábor Horváth, Gábor Tamás Tóth, Klaudia Farkas, János Banai, Zsolt Tulassay, Ferenc Nagy, Mária Szenes, Gábor Veres, Barbara D. Lovász, Zsuzsanna Végh, Petra A. Golovics, Miklós Szathmári, Mária Papp, Péter L. Lakatos

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

    Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Impo... per Lóránt Gönczi, Zsuzsanna Végh, Petra A. Golovics, Mariann Rutka, K Gecse, Renáta Bor, Klaudia Farkas, Tamás Szamosi, László Bene, Beáta Gasztonyi, Tünde Kristóf, Péter L. Lakatos, Pál Miheller, Károly Palatka, Mária Papp, Árpád Patai, Á Salamon, Gábor Tamás Tóth, Áron Vincze, E Bíró, Barbara D. Lovász, Zsuzsanna Kürti, Zoltán Szepes, Tamás Molnár, Péter L. Lakatos

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

    Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort per Lóránt Gönczi, K Gecse, Zsuzsanna Végh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra A. Golovics, Barbara D. Lovász, János Banai, László Bene, Bea Gasztonyi, Tünde Kristóf, L. Lakatos, Pál Miheller, Ferenc Nagy, Károly Palatka, Mária Papp, Árpád Patai, Á Salamon, T Szamosi, Zoltán Szepes, G Tóth, Áron Vincze, Balázs Szalay, Tamás Molnár, Péter L. Lakatos

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: